Kura Oncology Inc (NASDAQ:KURA)
| 18.19 Delayed Data As of Jun 24 |  +0.98 / +5.69%Today’s Change | 10.41 Today|||52-Week Range 23.00 | +29.93% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 1.0K | -- | 0.00 | 0.00 | ||
| Operating Expenses | Gross Income | -1.0K | 0.00 | 0.00 | 0.00 | |
| General Expenses | 16.0M | 16.6M | 15.0M | 15.9M | ||
| Research And Development | 11.7M | 12.1M | 10.4M | 11.4M | ||
| Total Operating Expenses | 16.0M | 16.6M | 15.0M | 15.9M | ||
| Non-Operating Expenses | Operating Income | -16.0M | -16.6M | -15.0M | -15.9M | |
| Extraordinary Charge | 0.00 | -498.0K | 0.00 | 0.00 | ||
| Interest Expense On Debt | 252.0K | 193.0K | 145.0K | 148.0K | ||
| Other Expenses | 180.0K | 180.0K | 126.0K | 74.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -15.0M | -16.1M | -13.9M | -14.9M | |
| Net Income | -15.0M | -16.1M | -13.9M | -14.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 37.8M | 38.1M | 38.2M | 38.9M | |
| Shares To Calculate EPS Diluted | 37.8M | 38.1M | 38.2M | 38.9M | ||
| Earnings Per Share | EPS | -$0.40 | -$0.42 | -$0.37 | -$0.38 | |
| EPS Diluted | -$0.40 | -$0.42 | -$0.37 | -$0.38 | ||
